Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-2-11
pubmed:abstractText
A 71-year-old woman with multiple myeloma (MM) in remission was admitted for evaluation of recent abdominal distension and was diagnosed as having massive myeloma ascites. The fluid was characterized by a total nucleated cell count of 6,600/mm3 (67% plasma cells), with a plasma cell CD38+ phenotype. Chemical analysis of the fluid showed lactate dehydrogenase of 122 IU/L, total protein of 2.9 g/dL, albumin of 2.4 g/dL, diastase of 38 IU/dL, cholesterol of 46 mg/dL, and C-reactive protein of 3 g/dL. The serum-ascites albumin gradient (SAAG) was low (0.9). Electrophoresis of the ascitic fluid showed a monoclonal spike in the gamma region and immunoelectrophoresis confirmed the presence of lambda light chains similar to those seen in the urine. Further analysis of the ascitic fluid showed markedly elevated levels of beta2 microglobulin (11,161 microg/L) and interleukin-6 (146 pg/ml compared to serum level of 4.3 pg/ml). There was evidence of intraabdominal masses that completely resolved with continuous high-dose cyclophosphamide (750 mg/m2/day for four days) followed by clinical improvement and disappearance of the ascites. We stress the value of complete fluid characterization and intensive chemotherapy to achieve a favorable outcome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ADP-ribosyl Cyclase, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD38, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/CD38 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin lambda-Chains, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/NAD Nucleosidase, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0361-8609
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
140-2
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:9929107-ADP-ribosyl Cyclase, pubmed-meshheading:9929107-Aged, pubmed-meshheading:9929107-Antigens, CD, pubmed-meshheading:9929107-Antigens, CD38, pubmed-meshheading:9929107-Antigens, Differentiation, pubmed-meshheading:9929107-Antineoplastic Agents, Alkylating, pubmed-meshheading:9929107-Ascites, pubmed-meshheading:9929107-C-Reactive Protein, pubmed-meshheading:9929107-Cell Count, pubmed-meshheading:9929107-Cholesterol, pubmed-meshheading:9929107-Cyclophosphamide, pubmed-meshheading:9929107-Female, pubmed-meshheading:9929107-Humans, pubmed-meshheading:9929107-Immunoelectrophoresis, pubmed-meshheading:9929107-Immunoglobulin lambda-Chains, pubmed-meshheading:9929107-Interleukin-6, pubmed-meshheading:9929107-L-Lactate Dehydrogenase, pubmed-meshheading:9929107-Membrane Glycoproteins, pubmed-meshheading:9929107-Multiple Myeloma, pubmed-meshheading:9929107-NAD+ Nucleosidase, pubmed-meshheading:9929107-Plasma Cells, pubmed-meshheading:9929107-Proteins, pubmed-meshheading:9929107-Proteinuria, pubmed-meshheading:9929107-beta 2-Microglobulin
pubmed:year
1999
pubmed:articleTitle
Myeloma ascites--a favorable outcome with cyclophosphamide therapy.
pubmed:affiliation
Department of Internal Medicine A, Bnai-Zion Medical Center, Haifa, Israel. drkeren@isdn.net.il
pubmed:publicationType
Journal Article, Case Reports